Trial Profile
Circadian changes in pharmacokinetics of Everolimus and to identify the time point relation with area under curve of Everolimus in heart transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Heart transplant rejection
- Focus Pharmacokinetics
- 01 Dec 2016 New trial record
- 26 Oct 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics